ANI Pharmaceuticals | ANIP - Loan Capital

Stock Price
81.60
Daily Change
0.10 0.12%
Monthly
5.32%
Yearly
35.57%
Q1 Forecast
79.33

ANI Pharmaceuticals reported $297.68M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
ANI Pharmaceuticals USD 297.68M 310.67M Sep/2025
Aurora Cannabis CAD 34.99M 1.31M Sep/2025
Canopy Growth CAD 226.33M 62.67M Sep/2025
Eli Lilly USD 40.87B 6.69B Sep/2025
Hikma Pharmaceutical USD 798M 191M Jun/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Novartis USD 24.24B 174M Sep/2025
Perrigo USD 3.61B 7.4M Sep/2025
Sun Pharmaceuticals INR 3.62B 36.4M Sep/2025
Teva Pharmaceutical Industries USD 14.99B 1.78B Dec/2025